{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:53:35Z","timestamp":1784768015914,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cjca.2023.08.035","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T21:05:27Z","timestamp":1695157527000},"page":"1808-1815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Revising the Roles of Aldosterone in Vascular Physiology and Pathophysiology: From Electocortin to Baxdrostat"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-0484","authenticated-orcid":false,"given":"Ross D.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Sanjanwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Padwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.08.035_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","article-title":"Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism","volume":"9","author":"Simpson","year":"1953","journal-title":"Experientia"},{"key":"10.1016\/j.cjca.2023.08.035_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib3","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1152\/ajprenal.1983.244.1.F35","article-title":"Intracellular microelectrode characterization of the rabbit cortical collecting duct","volume":"244","author":"Koeppen","year":"1983","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib4","first-page":"89","article-title":"Mineralocorticoid regulation of sodium and potassium transport by the cortical collecting duct","volume":"39","author":"Koeppen","year":"1985","journal-title":"Soc Gen Physiol Ser"},{"key":"10.1016\/j.cjca.2023.08.035_bib5","doi-asserted-by":"crossref","first-page":"F742","DOI":"10.1152\/ajprenal.1987.253.4.F742","article-title":"Effects of adrenalectomy on CCD: evidence for differential response of two cell types","volume":"253","author":"Muto","year":"1987","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib6","doi-asserted-by":"crossref","first-page":"F743","DOI":"10.1152\/ajprenal.1986.251.4.F743","article-title":"Effects of mineralocorticoids on transport properties of cortical collecting duct basolateral membrane","volume":"251","author":"Sansom","year":"1986","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.ph.53.030191.003025","article-title":"Structure-function relationship of Na,K-ATPase","volume":"53","author":"Horisberger","year":"1991","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1986.3","article-title":"Structure, function and regulation of Na,K-ATPase in the kidney","volume":"29","author":"J\u00f8rgensen","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2023.08.035_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1007009700377","article-title":"Transcriptional regulation of the human Na\/K ATPase via the human mineralocorticoid receptor","volume":"204","author":"Kolla","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cjca.2023.08.035_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/367463a0","article-title":"Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits","volume":"367","author":"Canessa","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2023.08.035_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.physiol.64.082101.143243","article-title":"Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors","volume":"64","author":"Rossier","year":"2002","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib12","doi-asserted-by":"crossref","first-page":"G718","DOI":"10.1152\/ajpgi.2000.278.5.G718","article-title":"Early aldosterone effect in distal colon by transcriptional regulation of ENaC subunits","volume":"278","author":"Epple","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib13","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1172\/JCI7840","article-title":"Aldosterone-mediated regulation of ENaC \u03b1, \u03b2, and \u03b3 subunit proteins in rat kidney","volume":"104","author":"Masilamani","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.08.035_bib14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/endo.142.4.8095","article-title":"The serum-and glucocorticoid-induced kinase is a physiological mediator of aldosterone action","volume":"142","author":"Bhargava","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjca.2023.08.035_bib15","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","article-title":"Epithelial sodium channel regulated by aldosterone-induced protein SGK","volume":"96","author":"Chen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2023.08.035_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mce.2003.10.043","article-title":"Regulation of sodium transport in mammalian collecting duct cells by aldosterone-induced kinase, SGK1: structure\/function studies","volume":"217","author":"N\u00e1ray-Fejes-T\u00f3th","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"3 pt 1","key":"10.1016\/j.cjca.2023.08.035_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ajh\/1.3.269","article-title":"Anatomical relationship between kallikrein-containing tubules and the juxtaglomerular apparatus in the human kidney","volume":"1","author":"Vio","year":"1988","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2023.08.035_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1986.94","article-title":"Immunocytochemical localization of renin and kallikrein in the rat renal cortex","volume":"29","author":"Barajas","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2023.08.035_bib19","doi-asserted-by":"crossref","first-page":"F427","DOI":"10.1152\/ajprenal.00072.2014","article-title":"Aldosterone sensitizes connecting tubule glomerular feedback via the aldosterone receptor GPR30","volume":"307","author":"Ren","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib20","doi-asserted-by":"crossref","first-page":"F1182","DOI":"10.1152\/ajprenal.00076.2016","article-title":"Mechanisms of connecting tubule glomerular feedback enhancement by aldosterone","volume":"311","author":"Ren","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1253\/circj.CJ-09-0050","article-title":"Aldosterone signaling associates with p300\/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes","volume":"74","author":"Yoshida","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2023.08.035_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-pharmtox-010716-104651","article-title":"GPER (GPR30): a nongenomic receptor (GPCR) for steroid hormones with implications for cardiovascular disease and cancer","volume":"57","author":"Feldman","year":"2017","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.cjca.2023.08.035_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fendo.2015.00153","article-title":"Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis","volume":"6","author":"Moss","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.cjca.2023.08.035_bib24","first-page":"706","article-title":"Effects of aldosterone on human atherosclerosis: plasma aldosterone and progression of carotid plaque","volume":"28","author":"de Rita","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2023.08.035_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/HYPERTENSIONAHA.110.158915","article-title":"C-reactive protein overexpression exacerbates pressure overload\u2013induced cardiac remodeling through enhanced inflammatory response","volume":"57","author":"Nagai","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib27","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1152\/ajpendo.00708.2006","article-title":"Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter","volume":"292","author":"Grossmann","year":"2007","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.cjca.2023.08.035_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Leopold","year":"2007","journal-title":"Nature medicine"},{"key":"10.1016\/j.cjca.2023.08.035_bib29","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/ndt\/gfs562","article-title":"Mineralocorticoid-receptor signalling in vascular smooth muscle","volume":"28","author":"Wu","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2023.08.035_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/HYPERTENSIONAHA.113.01273","article-title":"Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney","volume":"63","author":"DuPont","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/ATVBAHA.113.302854","article-title":"Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors","volume":"34","author":"Pruthi","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.08.035_bib32","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.09-147926","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Cat","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.cjca.2023.08.035_bib33","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00424-014-1616-x","article-title":"Role of smooth muscle cell mineralocorticoid receptor in vascular tone","volume":"467","author":"Tarjus","year":"2015","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.cjca.2023.08.035_bib34","first-page":"605","article-title":"Mineralocorticoid receptor on T cells contributes to injury and remodelling of ischemic myocardium","volume":"39","author":"Schiffrin","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cvr\/cvx097","article-title":"The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall","volume":"113","author":"Jia","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2023.08.035_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/hmbci-2014-0013","article-title":"Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR\/GR)","volume":"19","author":"Even","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.cjca.2023.08.035_bib37","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein\u2013coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cjca.2023.08.035_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/mend.16.1.0758","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cjca.2023.08.035_bib39","article-title":"The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries","volume":"13","author":"Yu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2023.08.035_bib40","doi-asserted-by":"crossref","first-page":"C1178","DOI":"10.1152\/ajpcell.00185.2009","article-title":"Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30","volume":"297","author":"Ding","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib41","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1210\/me.2005-0525","article-title":"Nature of functional estrogen receptors at the plasma membrane","volume":"20","author":"Pedram","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cjca.2023.08.035_bib42","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1210\/en.2008-0269","article-title":"G\u00a0protein\u2013coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol","volume":"149","author":"Otto","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjca.2023.08.035_bib43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.steroids.2009.12.006","article-title":"A\u00a0critical review of fundamental controversies in the field of GPR30 research","volume":"75","author":"Langer","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.cjca.2023.08.035_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrm2803","article-title":"Fine-tuning of GPCR activity by receptor-interacting proteins","volume":"10","author":"Ritter","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cjca.2023.08.035_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/mol.110.069500","article-title":"G\u00a0protein\u2013coupled estrogen receptor 1\/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments","volume":"79","author":"Sand\u00e9n","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cjca.2023.08.035_bib46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1042\/CS20160114","article-title":"GPER-novel membrane oestrogen receptor","volume":"130","author":"Zimmerman","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjca.2023.08.035_bib47","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A\u00a0transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cjca.2023.08.035_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nchembio.168","article-title":"In\u00a0vivo effects of a GPR30 antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cjca.2023.08.035_bib49","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","article-title":"GPR30 expression is required for the mineralocorticoid receptor\u2013independent rapid vascular effects of aldosterone","volume":"57","author":"Gros","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib50","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.0000093188.53554.44","article-title":"Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase\u2013dependent nitric oxide synthase activation","volume":"108","author":"Liu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.08.035_bib51","doi-asserted-by":"crossref","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","article-title":"Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation","volume":"304","author":"Gros","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tem.2015.09.002","article-title":"Copernicus revisited: overturning ptolemy\u2019s view of the GPER universe","volume":"26","author":"Feldman","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.08.035_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.tem.2015.05.005","article-title":"Nicolaus Copernicus and the rapid vascular responses to aldosterone","volume":"26","author":"Barton","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.08.035_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18632\/oncotarget.6475","article-title":"GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells","volume":"7","author":"Rigiracciolo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cjca.2023.08.035_bib55","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.mce.2013.11.005","article-title":"Anatomical location and redistribution of G protein\u2013coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone","volume":"382","author":"Cheng","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cjca.2023.08.035_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.995","article-title":"Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist","volume":"10","author":"Ding","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.cjca.2023.08.035_bib57","doi-asserted-by":"crossref","first-page":"H953","DOI":"10.1152\/ajpheart.00631.2015","article-title":"GPER activation ameliorates aortic remodeling induced by salt-sensitive hypertension","volume":"310","author":"Liu","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MNH.0000000000000702","article-title":"How common is primary aldosteronism?","volume":"30","author":"Hundemer","year":"2021","journal-title":"Current opinion in nephrology and hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib60","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib61","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1210\/jcem.80.12.8530580","article-title":"Primary aldosteronism (Conn\u2019s syndrome)","volume":"80","author":"Gittler","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.08.035_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"10.1016\/j.cjca.2023.08.035_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1964.03070160046009","article-title":"Plasma renin activity in primary aldosteronism: importance in differential diagnosis and in research of essential hypertension","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.08.035_bib64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic primary aldosteronism: a detectable cause of curable essential hypertension","volume":"193","author":"Conn","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.08.035_bib65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","article-title":"Incidence of primary aldosteronism uncomplicated essential hypertension: a prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria","volume":"205","author":"Fishman","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.08.035_bib66","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.08.035_bib67","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jama.1960.63020150008016","article-title":"Evolution of primary aldosteronism as a highly specific clinical entity","volume":"172","author":"Conn","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.08.035_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12022-021-09667-0","article-title":"What did we learn from the molecular biology of adrenal cortical neoplasia? From histopathology to translational genomics","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.cjca.2023.08.035_bib69","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib70","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A\u00a0screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib71","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.08.035_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","author":"Ito","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjca.2023.08.035_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2013a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cjca.2023.08.035_bib74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib75","first-page":"196","article-title":"Primary aldosteronism in hypertension: more than a factoid","volume":"37","author":"Feldman","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib76","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib77","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.08.035_bib78","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib79","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","article-title":"Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone","volume":"28","author":"Ori","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2023.08.035_bib80","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.cjca.2023.08.035_bib81","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cjca.2023.08.035_bib82","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Resistant hypertension characterized by increased aldosterone levels and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib83","first-page":"681","article-title":"Epidemiology of resistant hypertension in Canada","volume":"38","author":"Leung","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.08.035_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among US veterans: a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2023.08.035_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and nonsteroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.08.035_bib86","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1751-7176.2011.00495.x","article-title":"Spironolactone is more effective than eplerenone at lowering blood pressure in patients with primary aldosteronism","volume":"13","author":"Bloch","year":"2011","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.cjca.2023.08.035_bib87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40119-022-00269-3","article-title":"Cardiovascular and renal outcomes with finerenone, a selective mineralocorticoid receptor antagonist","volume":"11","author":"Palanisamy","year":"2022","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.cjca.2023.08.035_bib88","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.116.07716","article-title":"Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase (CYP11B2)","volume":"69","author":"Bogman","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.08.035_bib89","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N\u00a0Engl J Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23017324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23017324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:55:58Z","timestamp":1760108158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23017324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0828282X23017324"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.08.035","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revising the Roles of Aldosterone in Vascular Physiology and Pathophysiology: From Electocortin to Baxdrostat","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}